Sandor Victor bought PRLD
November 5, 2025 · Form 4 insider transaction
Sandor Victor bought 121,285 shares of Prelude Therapeutics Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
121,285
Price
$0.00
Total value
N/A
InsiderSandor Victor
RoleDirector
SecurityDirector Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateNovember 5, 2025
Filing dateNovember 7, 2025
Shares owned after121,285
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option award vests over a one year period equally one-twelfth per month, subject to Reporting Person's continued service to the Company on each vesting date.